Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
10.46
-0.10 (-0.95%)
At close: Feb 27, 2026, 4:00 PM EST
10.45
-0.01 (-0.10%)
After-hours: Feb 27, 2026, 7:27 PM EST
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $195.63 million as of February 27, 2026.
Market Cap
195.63M
Enterprise Value
120.17M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.46
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $195.63M, a decrease of -8.81%. That is a compound annual growth rate of -9.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 195.63M | 23.93% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 206.73M |
| Canton Strategic Holdings | 200.42M |
| NeOnc Technologies Holdings | 199.03M |
| Cartesian Therapeutics | 197.37M |
| SAB Biotherapeutics | 195.19M |
| Galectin Therapeutics | 192.13M |
| Nkarta | 191.78M |
| Acumen Pharmaceuticals | 190.20M |